Mainz Biomed B.V.

NASDAQ: MYNZ · Real-Time Price · USD
1.76
0.07 (4.14%)
At close: Aug 15, 2025, 3:59 PM
1.69
-3.98%
After-hours: Aug 15, 2025, 05:30 PM EDT

Mainz Biomed B.V. Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-21.65M -16.21M -13.44M -22.04M -26.39M -24.03M -11.67M -534.2K
Depreciation & Amortization
1.02M 701.42K 375.49K 488.44K 379.8K 97.46K 69.93K 65.06K
Stock-Based Compensation
1.14M 1.85M 2.92M 6.24M 9.82M 12.11M 8.04M 1.61M
Other Working Capital
-42.34K 257.96K 1.71M 1.52M -53.79K -508.62K -816.25K 102.82K
Other Non-Cash Items
2.36M 246.85K -708.1K 1.7M 1.85M 2.81M 2.78M 119.59K
Deferred Income Tax
n/a -17.54K -17.54K n/a n/a -6.49M -8.22M -1.74M
Change in Working Capital
51.75K 629.06K 2.02M 1.1M -437.4K -537.72K -772.17K 40.78K
Operating Cash Flow
-17.09M -12.8M -9.77M -13.43M -14.77M -9.54M -3.32M -463.14K
Capital Expenditures
-254.95K -382.47K -385.43K -529.66K -658.48K -264.57K -16.7K -9.42K
Cash Acquisitions
32.78K n/a n/a n/a n/a 1.22M 1.22M n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-126.65K -500K -700K -500K n/a 1.22M 1.22M 4.84K
Investing Cash Flow
-198.82K -794.95K -497.91K -529.66K -658.48K 955.28K 1.2M -9.42K
Debt Repayment
3.13M 67.44K 2.42M 4.39M -45.69K -45.69K 217.03K 217.03K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-295.25K 1.45M 934.87K -148.23K 23.99M 34.53M 10.39M 19.44K
Financial Cash Flow
16.6M 6.02M 8.88M 5.27M 23.94M 34.49M 10.9M 483.56K
Net Cash Flow
6.24M -1.27M -2.2M -25.95M n/a 27.99M 2.23M 203.08K
Free Cash Flow
-17.34M -13.18M -10.16M -13.96M -15.43M -9.81M -3.33M -472.56K